Current location - Plastic Surgery and Aesthetics Network - Plastic surgery and medical aesthetics - Shanghai haohai biotechnology co., ltd.
Shanghai haohai biotechnology co., ltd.
Shanghai Haohai Biotechnology Co., Ltd. (Haohai Ke Sheng) is a high-tech biomedical enterprise. The registered capital of the company is RMB 65438+200 million, and it has an internationally competitive R&D, production, sales, investment platform and management team. Haohaishengke's main business covers biological materials, biological agents and genetic engineering drugs.

Haohaishengke has established a biopharmaceutical enterprise in Songjiang Industrial Zone, Shanghai, which meets the national GMP standards, passed the national ISO900 1 quality control system certification, and is preparing for the verification of EU CE and US FDA standards. Specializing in the production of a full range of biodegradable biomaterial sodium hyaluronate with wide clinical application prospects, water-soluble medical chitosan and collagen series specialized products with independent intellectual property rights, as well as the national first-class new drug "recombinant human epidermal growth factor and related products. The clinical application of the product involves ophthalmology, orthopedics, general surgery, obstetrics and gynecology, plastic surgery, burn department and dermatology.

Shanghai Qisheng Biological Preparation Co., Ltd. is a wholly-owned subsidiary of Haohai Ke Sheng. Is a high-tech enterprise with strong technical force, advanced production equipment and excellent service quality, which integrates the design, development, production and service of medical biomaterials. Enterprises always adhere to the purpose of "product quality first, company reputation first, economic benefit first, service user first", and take "increasing its award-winning honor, building its award-winning image, building its award-winning culture and strengthening its award-winning brand" as the goal, and constantly strengthen corporate culture construction. The company's main products are the second generation of medical sodium hyaluronate, medical chitosan, medical collagen sponge and artificial tears for eyes. The technology is equivalent to similar products abroad in the middle and late 1990s, and it is in a leading position in China. This product has high clinical value in effectively preventing tissue adhesion after ophthalmic microsurgery, joint disease treatment, surgery, orthopedics and obstetrics and gynecology surgery, hemostasis in clinical departments, wound and defect filling, eye care and so on. All products are Shanghai high-tech achievements transformation projects and national key new products, which have been included in the national torch plan project and the 100 promotion projects of the Ministry of Health for ten years. The company's marketing network covers more than 20 provinces, cities and regions in China, with annual sales exceeding 45 million yuan. The domestic market share of Shanghai famous brand "Qisheng" medical sodium hyaluronate and medical chitosan is 30% and 100% respectively.